NCT00855062 | Johns Hopkins University|Makerere University | HIV-associated Cognitive Impairment|HIV Infections | April 2008 | Phase 1|Phase 2 |
NCT02928692 | RenJi Hospital|Shanghai 10th People´s Hospital|Pudong New Area People´s Hospital|Shanghai Pudong Hospital|Shanghai Pudong New Aera Dongming Community Health Care Center | Prostate Cancer|Carcinoma of the Rectum|Colon Cancer|Renal Carcinoma | November 2016 | Phase 3 |
NCT02770378 | University of Ulm|Reliable Cancer Therapies|Anticancer Fund, Belgium | Glioblastoma | November 2016 | Phase 1|Phase 2 |
NCT02695446 | BioPharmX, Inc. | Acne | March 2016 | Phase 4 |
NCT01048983 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Non Small Cell Lung Cancer | | Phase 1|Phase 2 |
NCT01636934 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Lung Cancer | July 2012 | Phase 2 |
NCT00916461 | Stanley Medical Research Institute|Rawalpindi Medical College, Pakistan|Pakistan Institute of Living and Learning|University of Sao Paulo | First Episode Psychosis | May 2006 | Phase 1|Phase 2 |
NCT02359006 | Yale University|National Institute on Drug Abuse (NIDA) | Opioid Dependence|Pain | March 12, 2015 | Not Applicable |
NCT00666887 | Dr. Luanne Metz|Multiple Sclerosis Society of Canada|University of Calgary | Clinically Isolated Syndromes|Early Single Relapse of Multiple Sclerosis | January 2009 | Phase 3 |
NCT02815267 | Vyne Therapeutics Inc. | Acne Vulgaris | May 2016 | Phase 3 |
NCT01317550 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Lung Cancer | July 2011 | Not Applicable |
NCT01134627 | Merck KGaA, Darmstadt, Germany | Multiple Sclerosis, Relapsing-Remitting | February 2006 | Phase 2 |
NCT00836355 | NYU Langone Health|James N. Kirby Foundation | Acute Ischemic Stroke | April 2009 | Not Applicable |
NCT02533232 | Pakistan Institute of Living and Learning | Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder | August 30, 2022 | Phase 1 |
NCT02913118 | Qingfeng Pharmaceutical Group | Community Acquired Pneumonia | July 2016 | Phase 4 |
NCT03291158 | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)|Universitätsklinikum Köln|Innovative Medicines Initiative | Normal Healthy Volunteers | April 2018 | Phase 1 |
NCT02203552 | Ohio State University Comprehensive Cancer Center | Anxiety Disorder|Depression|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer | June 23, 2015 | Phase 2 |
NCT01574742 | Shalvata Mental Health Center | Unipolar Depression | June 2012 | Phase 1 |
NCT01561742 | The University of Texas Health Science Center, Houston|Stanley Medical Research Institute | Schizophrenia | February 2012 | Not Applicable |
NCT03762915 | University of Minnesota|Bausch Health Companies, INC. | SRP|Minocycline HCl Microspheres|Biomarkers | May 20, 2019 | Phase 4 |
NCT02515955 | Janssen-Cilag International NV | Healthy | August 2015 | Phase 1 |
NCT01517334 | OraPharma | Peri-Implantitis | May 2012 | Phase 3 |
NCT03667222 | BioPharmX, Inc. | Papulopustular Rosacea | September 18, 2018 | Phase 2 |
NCT04291456 | University of Calgary|Hotchkiss Brain Institute, University of Calgary|Multiple Sclerosis Society of Canada | Multiple Sclerosis|Clinically Isolated Syndrome | January 31, 2020 | Phase 3 |
NCT01580969 | University of Utah | Recurrent Glioma | July 6, 2012 | Phase 1|Phase 2 |
NCT01809340 | Janssen Research & Development, LLC | Depressive Disorder | June 2013 | Phase 2 |
NCT00154895 | National Taiwan University Hospital|National Science Council, Taiwan | Pneumothorax | June 2001 | Phase 3 |
NCT00145106 | KGL, Inc.|Milton S. Hershey Medical Center|State University of New York - Downstate Medical Center|Jefferson Medical College of Thomas Jefferson University|NYU Langone Health|Allergan | Acne Vulgaris | March 2002 | Phase 4 |
NCT04478500 | Royal Perth Hospital | Resistant Hypertension | July 2, 2020 | Phase 3 |
NCT02808052 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)|Universitätsklinikum Köln|Innovative Medicines Initiative|Melinta Therapeutics, Inc. | Renal Insufficiency, Acute|Renal Insufficiency, Chronic|Healthy Subjects | May 29, 2017 | Phase 1 |
NCT05836740 | Beijing Tiantan Hospital|NeuroDawn Pharmaceutical Co., Ltd. | Ischemic Stroke, Acute | May 19, 2023 | Phase 3 |
NCT01802216 | University of California, San Francisco | Chronic Kidney Disease|Periodontal Disease | February 2014 | Not Applicable |
NCT03947827 | Centre for Addiction and Mental Health|The Physicians´ Services Incorporated Foundation | Treatment Resistant Depression | February 1, 2020 | Phase 3 |
NCT00029874 | FDA Office of Orphan Products Development | Huntington´s Disease | September 2001 | Phase 1|Phase 2 |
NCT01938508 | GlaxoSmithKline|CECYC (Center of Scientific and Clinical Studies, CRO) | Skin Diseases | May 2013 | Phase 1 |
NCT00556491 | Tarek M. El-Achkar|Satellite Healthcare|Triax Pharmaceuticals|St. Louis University | Kidney Failure, Acute|Acute Kidney Insufficiency | December 2007 | Not Applicable |
NCT03117530 | University of California, Los Angeles | Autism Spectrum Disorder | April 11, 2017 | Phase 1 |
NCT00559494 | University of Calgary|Paralyzed Veterans of America|American Association of Neurological Surgeons|Hotchkiss Brain Institute, University of Calgary | Spinal Cord Injuries | June 2004 | Phase 1|Phase 2 |
NCT00418392 | National Taiwan University Hospital | Pneumothorax | November 2006 | Phase 3 |
NCT03142451 | Vyne Therapeutics Inc.|Premier Research Group plc | Facial Papulopustular Rosacea | June 2, 2017 | Phase 3 |
NCT03160040 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)|Melinta Therapeutics, Inc. | Gram-Negative Bacterial Infections | October 11, 2017 | |
NCT00893724 | Mid-Atlantic Retina Consultations, Inc.|West Virginia University | Neovascular Age-related Macular Degeneration|Diabetic Macular Edema | June 2009 | Not Applicable |
NCT02213575 | University of Florida|National Heart, Lung, and Blood Institute (NHLBI) | Hypertension | April 15, 2024 | Phase 2 |
NCT05474729 | Sun Yat-sen University | Minocycline|Uveitis|Retinal Degeneration | December 1, 2021 | Phase 1|Phase 2 |
NCT05902819 | Psychiatric University Hospital, Zurich|University of Zurich | Post-traumatic Stress Disorder|Cocaine Use Disorder | May 10, 2023 | Not Applicable |
NCT03040128 | University of Tennessee|University of Southern California | Intracerebral Hemorrhage | June 27, 2013 | Phase 1|Phase 2 |
NCT02712775 | Medical University of South Carolina | Liver Disease | March 2016 | Phase 4 |
NCT01828203 | Rick Hansen Institute|University of Calgary|Alberta Paraplegic foundation | Spinal Cord Injuries | June 2013 | Phase 3 |
NCT03050086 | BioPharmX, Inc. | Moderate to Severe Papulopustular Rosacea | March 29, 2017 | Phase 1|Phase 2 |
NCT00456677 | State University of New York - Downstate Medical Center | Asthma | June 1996 | Phase 2 |
NCT01531582 | University of South Florida | Angelman Syndrome | April 2012 | Not Applicable |
NCT05861258 | Radboud University Medical Center | Mycobacterium Avium Complex Pulmonary Disease | May 8, 2023 | Phase 2 |
NCT01539564 | OraPharma | Peri-Implantitis | April 2012 | Phase 3 |
NCT01283997 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Myeloma | January 25, 2011 | Phase 2 |
NCT01134991 | Vyne Therapeutics Inc. | Rosacea | June 2010 | Phase 2 |
NCT04433143 | Gang Wang|Xijing Hospital | Acne Vulgaris | May 15, 2020 | Not Applicable |
NCT02947763 | Cairo University | Periapical Periodontitis | November 2016 | Phase 1 |
NCT05530252 | Beijing Stomatological Hospital, Capital Medical University | Periodontitis | September 5, 2022 | Phase 4 |
NCT01297816 | Shahid Beheshti University of Medical Sciences | Retinal Detachment | December 2010 | Phase 2 |
NCT00668746 | OraPharma | Periodontitis | December 2007 | Phase 4 |
NCT03340350 | Sriram Ramaswamy|Creighton University|VA Nebraska Western Iowa Health Care System | PTSD | May 10, 2017 | Phase 4 |
NCT01133080 | Shalvata Mental Health Center | Schizophrenia | June 2010 | Phase 4 |
NCT01403662 | University Health Network, Toronto | Bipolar Disorder|Bipolar Depression|Bipolar I Depression|Bipolar II Depression | July 2011 | Phase 3 |
NCT04219735 | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Delirium|Coma | January 30, 2020 | Phase 2 |
NCT05826912 | University of California, San Francisco|United States Department of Defense | Traumatic Brain Injury | August 30, 2023 | Phase 2 |
NCT05680389 | Leiden University Medical Center | Cerebral Amyloid Angiopathy | December 2, 2020 | Phase 1|Phase 2 |
NCT00203697 | University of California, Los Angeles | Idiopathic Pulmonary Fibrosis | | Phase 3 |
NCT01813240 | Hadassah Medical Organization | Spinal Tumors, Trauma Patients, Minocycline. | May 2013 | Phase 2|Phase 3 |
NCT05958069 | Xijing Hospital | Epileptic Seizures Related to Drugs | March 1, 2023 | Not Applicable |
NCT01349192 | University of North Carolina, Chapel Hill|CF Therapeutics Development Network Coordinating Center|Seattle Children´s Hospital|Washington University School of Medicine|University of Washington|University of Colorado, Denver|Baylor College of Medicine|University of Alabama at Birmingham|Cook Children´s Medical Center|University of Michigan|University of Florida|University of Texas Southwestern Medical Center|Children´s Hospital Medical Center, Cincinnati|St. Louis Children´s Hospital | Cystic Fibrosis|Methicillin-resistant Staphylococcus Aureus | April 2011 | Phase 2 |
NCT04594733 | Medical University of South Carolina | Fibromyalgia | December 6, 2021 | Phase 1|Phase 2 |
NCT00765336 | Medicis Pharmaceutical Corporation | Human Volunteer | November 2006 | Phase 4 |
NCT01468844 | National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC) | Retinal Vein Occlusion | December 21, 2011 | Phase 1|Phase 2 |
NCT02263872 | Pakistan Institute of Living and Learning|King´s College London | Depressive Disorder|Mood Disorders|Depressive Disorder, Treatment Resistant|Antidepressive Agents | October 2014 | Phase 4 |
NCT01779089 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Diabetic Nephropathy | February 2009 | Not Applicable |
NCT00776542 | Ranbaxy Laboratories Limited|Ranbaxy Inc. | Healthy | October 2002 | Not Applicable |
NCT01422148 | Baystate Medical Center | Atrial Fibrillation | February 2024 | Phase 2 |
NCT02362529 | Centre for Addiction and Mental Health | Major Depressive Disorder | February 2015 | Early Phase 1 |
NCT04608500 | Vyne Therapeutics Inc.|Premier Research Group plc | Facial Papulopustular Rosacea | June 1, 2017 | Phase 3 |
NCT02312297 | Ranbaxy Laboratories Limited|Ranbaxy Inc. | Healthy | September 2008 | Not Applicable |
NCT02187211 | Yale University|United States Department of Defense|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Dependence | July 1, 2015 | Phase 1 |
NCT04020588 | Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | Schizophrenia | February 25, 2019 | Phase 4 |
NCT00515255 | Neuropharm | Obsessive Compulsive Disorder | July 2007 | Phase 2 |
NCT00988026 | Darier | Mild to Moderate Acne | June 2009 | Phase 4 |
NCT00733057 | Shalvata Mental Health Center|Abarbanel Mental Health Center | Negative and Cognitive Symptoms in Schizophrenia | August 2003 | Phase 3 |
NCT05630534 | Second Affiliated Hospital, School of Medicine, Zhejiang University|The Fourth Affiliated Hospital of Zhejiang University School of Medicine|The Second Affiliated Hospital of Jiaxing University | Intracerebral Hemorrhage | January 1, 2023 | Phase 1 |
NCT05014906 | Dermatology Specialists Research | Rosacea | May 2010 | Phase 4 |
NCT04076098 | Mahsa University | Periodontitis, Adult | June 25, 2018 | Phase 4 |
NCT05474950 | Sun Yat-sen University | Minocycline|Cystoid Macular Edema | January 1, 2019 | Phase 1|Phase 2 |
NCT00270751 | National Taiwan University Hospital|National Science Council, Taiwan | Pneumothorax | April 2005 | Phase 2|Phase 3 |
NCT03244592 | University of California, Los Angeles|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder|Inflammation|Neurocognitive Dysfunction|Craving|Alcohol Drinking | January 15, 2018 | Phase 1|Phase 2 |
NCT00243893 | University of California, San Francisco|National Institute of Neurological Disorders and Stroke (NINDS) | Aneurysms|Arteriovenous Malformations | July 2004 | Phase 1 |
NCT00361257 | AIDS Clinical Trials Group|National Institute of Allergy and Infectious Diseases (NIAID)|Neurologic AIDS Research Consortium (NARC) | HIV Infections | March 2007 | Phase 2 |
NCT00839553 | Far Eastern Memorial Hospital|National Taiwan University Hospital|Department of Health | Pneumothorax | April 2007 | Not Applicable |
NCT00047723 | National Institute of Neurological Disorders and Stroke (NINDS) | Amyotrophic Lateral Sclerosis | January 2003 | Phase 3 |
NCT00409747 | National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC) | Autism|Minocycline|Regressive Autism | November 2006 | Phase 4 |
NCT01429272 | Laureate Institute for Brain Research, Inc.|Stanley Medical Research Institute|University of Oklahoma | Bipolar Disorder Depression | September 2011 | Phase 3 |
NCT03507556 | Jordan University of Science and Technology | Revascularization | June 28, 2010 | Not Applicable |
NCT02815332 | BioPharmX, Inc. | Acne Vulgaris | August 2016 | Phase 2 |
NCT01053156 | University of California, Davis|The National Fragile X Foundation | Fragile X Syndrome | January 2010 | Not Applicable |
NCT01869907 | Ziekenhuis Oost-Limburg | Neuropathic Pain Caused by Lumbar Radicular Pain | September 2011 | Phase 4 |
NCT02968602 | University of Maryland, Baltimore|National Institute on Drug Abuse (NIDA) | Schizophrenia|Tobacco Use | March 31, 2017 | Phase 4 |
NCT01219673 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Head And Neck Cancer | March 2013 | Phase 1|Phase 2 |
NCT03414502 | University of Nebraska | Rheumatoid Arthritis | August 2007 | Phase 3 |
NCT01362010 | Vyne Therapeutics Inc. | Acne Vulgaris | January 2012 | Phase 2 |
NCT03320018 | Stony Brook University | Stroke, Ischemic | August 2, 2017 | Phase 2|Phase 3 |
NCT02946788 | BioPharmX, Inc. | Acne Vulgaris | March 13, 2017 | Phase 2 |
NCT01647282 | University of Nebraska | Moderate to Advanced Chronic Periodontitis | September 2012 | Phase 4 |
NCT02113176 | University at Buffalo|University at Buffalo Neurosurgery | Subarachnoid Aneurysm Hemorrhage | January 2010 | Phase 1|Phase 2 |
NCT02312609 | Ranbaxy Laboratories Limited|Ranbaxy Inc. | Healthy | September 2008 | Not Applicable |
NCT04036890 | National Dental Centre, Singapore | Periodontitis | June 3, 2016 | Phase 4 |
NCT04210713 | University of Maryland, Baltimore|National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Drinking|Alcohol-Related Disorders|Disease|Inflammation|Alcoholism|Cognitive Dysfunction|Pathologic Processes|Drinking Behavior|Substance-Related Disorders|Chemically-Induced Disorders|Mental Disorder|Cognition Disorder|Neurocognitive Disorders|Minocycline|Anti-Bacterial Agents|Anti-Infective Agents | February 3, 2020 | Phase 1 |
NCT01314482 | University of Adelaide | Post-operative Intercostal Neuralgia | November 2010 | Phase 2 |
NCT00579644 | University of Nebraska | Rheumatoid Arthritis | January 2001 | Phase 3 |
NCT03768557 | University of Oxford | Mood|Cognitive Change | April 26, 2017 | Not Applicable |
NCT04202263 | State University of New York - Downstate Medical Center | Allergic Rhinitis|Asthma | September 26, 2019 | Phase 2 |
NCT01320982 | Sheba Medical Center | Schizophrenia|Schizoaffective Disorder | March 2011 | Phase 3 |
NCT01793051 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Myeloma | March 22, 2013 | Phase 2 |
NCT00858689 | FRAXA Research Foundation|Fragile X Research Foundation of Canada | Fragile X Syndrome | October 2007 | Not Applicable |
NCT05605366 | University of Cincinnati | Sickle Cell Disease|Cognitive Impairment|Cognitive Decline|Cognitive Change|Cognitive Dysfunction|Cognitive Deficit|Neuroinflammatory Response | July 1, 2023 | Phase 1 |
NCT02055963 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Head And Neck Cancer | May 6, 2014 | Phase 2 |
NCT05512910 | Xijing Hospital|Xi´an No.3 Hospital|Xi´an Gaoxin Hospital|First People´s Hospital of Xianyang|Xi´an XD Group Hospital|Central Hospital of Gansu Province | Ischemic Stroke, Acute|Minocycline|Endovascular Treatment|Basilar Artery Occlusion | December 13, 2022 | Phase 4 |
NCT03263273 | Hovione Scientia Limited | Rosacea|Papulopustular Rosacea | October 30, 2017 | Phase 2 |
NCT01463384 | Huntington Medical Research Institutes | Mild Cognitive Impairment|Alzheimer´s Disease | September 2011 | Phase 2 |
NCT03489629 | University of North Carolina, Chapel Hill|University of Washington|Cook Children´s Medical Center|Indiana University|University of Michigan|University of Texas Southwestern Medical Center|St. Louis Children´s Hospital | Cystic Fibrosis | April 3, 2018 | Phase 2 |
NCT04031755 | Children´s Hospital Medical Center, Cincinnati | Autism Spectrum Disorder|Autism | April 19, 2019 | Phase 1 |
NCT00392223 | Pfizer | Acne Vulgaris | October 2007 | Phase 3 |
NCT02998151 | Children´s Hospital Medical Center, Cincinnati|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Fragile X Syndrome | January 2016 | Early Phase 1 |
NCT02815280 | Vyne Therapeutics Inc. | Acne Vulgaris | May 2016 | Phase 3 |
NCT00777413 | Ranbaxy Laboratories Limited|Ranbaxy Inc. | Healthy | November 2002 | Not Applicable |
NCT02765100 | Weill Medical College of Cornell University|Weill Cornell Medical College in Qatar | Bipolar Disorder|Depression|Obesity | October 2014 | Not Applicable |
NCT00401921 | Brigham and Women´s Hospital | Carotid Stenosis | October 2006 | Phase 2 |
NCT02907437 | Beer Yaakov - Ness Ziona Mental Health Center|Bar-Ilan University, Israel | Schizophrenia | January 2015 | Phase 3 |
NCT04068207 | Sun Yat-sen University | Retinitis Pigmentosa|Inherited Retinal Dystrophy|Retina Disorder | February 22, 2019 | Phase 2 |
NCT01433055 | University of Maryland, Baltimore|National Institute of Mental Health (NIMH) | Schizophrenia | July 2011 | Not Applicable |
NCT00473083 | British Columbia Cancer Agency|Hoffmann-La Roche | Rash | January 2009 | Phase 2 |
NCT02272270 | University of Utah | Newly Diagnosed High Grade Glioma | October 27, 2014 | Phase 1 |
NCT01693523 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Pancreatic Cancer | January 28, 2013 | Phase 2 |
NCT02193269 | Yale University | Memory Impairment | July 8, 2013 | Phase 1 |
NCT02719392 | Massachusetts General Hospital | Bipolar Disorder|Bipolar Depression | August 9, 2017 | Phase 4 |
NCT02124811 | Emory University | Schizophrenia|Schizoaffective Disorder | February 2015 | Phase 4 |
NCT02201563 | University of Pittsburgh | Irradiation; Adverse Effect | November 2015 | Phase 1 |
NCT00371332 | OraPharma | Periodontitis | January 2004 | Phase 3 |
NCT01064752 | University of California, San Francisco | HIV Infection | April 2005 | |
NCT02802631 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)|Universitätsklinikum Köln|Innovative Medicines Initiative|Melinta Therapeutics, Inc. | Normal Healthy Volunteers | April 20, 2017 | Phase 1 |
NCT02541500 | Universiti Sains Malaysia|Yale University | Heroin Dependence|Amphetamine Dependence | April 2013 | Phase 3 |
NCT02355977 | Zhejiang University|Academic Centre for Dentistry in Amsterdam | Chronic Periodontitis | June 2013 | Phase 4 |
NCT04104685 | Vyne Therapeutics Inc. | Acne Vulgaris | September 18, 2019 | Phase 2 |
NCT01809158 | Addis Ababa University|Stanley Medical Research Institute | Schizophrenia | April 2013 | Phase 4 |
NCT02456948 | Charite University, Berlin, Germany | Major Depressive Disorder | January 2015 | Phase 2 |
NCT01514422 | Icahn School of Medicine at Mount Sinai | Bipolar Depression | May 2011 | Phase 4 |
NCT00662532 | OraPharma | Periodontitis | April 2008 | Phase 3 |
NCT00203112 | Teva Branded Pharmaceutical Products R&D, Inc. | Relapse Remitting Multiple Sclerosis | June 2004 | Phase 2 |
NCT02928965 | University of Manchester|University of Edinburgh|University of Cambridge|University College, London|University of Birmingham|King´s College London|Manchester Mental Health & Social Care Trust|Greater Manchester Mental Health NHS Foundation Trust|Northern Care Alliance NHS Foundation Trust|Lancashire Care NHS Foundation Trust|Cambridgeshire and Peterborough NHS Foundation Trust|West London Mental Health NHS Trust|North East London Foundation Trust|Central and North West London NHS Foundation Trust|Camden and Islington NHS Foundation Trust|South London and Maudsley NHS Foundation Trust|NHS Lothian|NHS Fife|NHS Borders|University Hospital Birmingham NHS Foundation Trust | Schizophrenia and Disorders With Psychotic Features | February 2013 | Phase 2 |
NCT02178813 | University of Pittsburgh | Stroke | July 2014 | Phase 1 |
NCT02250859 | Vyne Therapeutics Inc. | Acne | September 2014 | Phase 1 |
NCT00930020 | Singhealth Foundation|National Neuroscience Institute|Changi General Hospital | Acute Stroke | July 2009 | Phase 4 |
NCT00529555 | Sunstar Americas | Adult Periodontitis | January 2006 | Phase 3 |
NCT01659320 | Weill Medical College of Cornell University|National Institute of Mental Health (NIMH) | Depression | March 2012 | Not Applicable |
NCT00630396 | David Hess, MD|National Institute of Neurological Disorders and Stroke (NINDS)|University of Kentucky|Oregon Health and Science University|Augusta University | Stroke, Acute | May 2008 | Phase 1|Phase 2 |
NCT01171326 | Vyne Therapeutics Inc. | Impetigo | August 2010 | Phase 2 |
NCT00240513 | Derm Research @ 888 Inc.|Stiefel, a GSK Company | Acne Vulgaris | August 2004 | Phase 4 |
NCT02703363 | Pakistan Institute of Living and Learning|Dow University of Health Sciences|Abbasi Shaheed Hospital|Rawalpindi Medical College, Pakistan|University of Manchester|Stanley Medical Research Institute | Depression|Bipolar Disorder|Bipolar Depression|Mood Disorders | August 2016 | Phase 3 |
NCT01906008 | M.D. Anderson Cancer Center|American Cancer Society, Inc. | Colorectal Cancer | November 2013 | Phase 2 |
NCT02051296 | VA Palo Alto Health Care System|Stanford University | Chronic Pain|Post-operative Pain | January 2012 | Phase 2 |
NCT01805895 | Augusta University|American Heart Association | Intracerebral Hemorrhage | February 2013 | Phase 1|Phase 2 |
NCT05452785 | Journey Medical Corporation|Dr. Reddy´s Laboratories Limited | Pharmacokinetics | May 7, 2022 | Phase 1 |
NCT01746043 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Esophageal Cancer | February 2013 | Phase 2 |
NCT05487417 | Xijing Hospital|Xi´an No.3 Hospital|Xi´an Gaoxin Hospital|First People´s Hospital of Xianyang|Xi´an XD Group Hospital | Ischemic Stroke, Acute | November 1, 2022 | Phase 4 |
NCT05597462 | Journey Medical Corporation|Dr. Reddy´s Laboratories Limited | Rosacea | September 30, 2022 | Phase 1 |
NCT01600625 | Yonsei University | Meibomian Gland Dysfunction | November 2011 | Not Applicable |
NCT02133872 | University of Florida|National Heart, Lung, and Blood Institute (NHLBI) | Hypertension | October 2014 | Phase 4 |
NCT02564978 | National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC) | Age-Related Macular Degeneration | December 14, 2016 | Phase 2 |
NCT01058395 | Wayne State University | Traumatic Brain Injury | February 2010 | Phase 1|Phase 2 |
NCT01755611 | GlaxoSmithKline | Skin Infections (Acne) | June 17, 2011 | Phase 1 |
NCT01073813 | University of Calgary|Neuroscience Canada | Multiple Sclerosis|Optic Neuritis | February 2010 | Phase 2 |
NCT04558502 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Helicobacter Pylori Eradication | January 5, 2022 | Phase 4 |
NCT00355576 | Columbia University|ALS Association|Pfizer | Amyotrophic Lateral Sclerosis | July 2006 | Phase 2 |
NCT04125706 | Riyadh Elm University | Periodontitis | November 1, 2019 | Not Applicable |
NCT01695291 | New York State Psychiatric Institute|National Institute of Mental Health (NIMH)|Weill Medical College of Cornell University | Obsessive Compulsive Disorder | May 2012 | Phase 2 |
NCT01173692 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Oropharynx Cancer | July 22, 2010 | Phase 2 |
NCT00536042 | State University of New York - Downstate Medical Center | Asthma | October 1997 | Phase 2 |
NCT02030912 | Helperby Therapeutics Ltd|Richmond Pharmacology Limited | Antibiotic Resistant Bacteria | December 2009 | Phase 4 |
NCT03369951 | National Institute of Allergy and Infectious Diseases (NIAID) | Bacterial Infection | March 28, 2018 | Phase 4 |
NCT03106740 | Marco Loggia|National Institute of Neurological Disorders and Stroke (NINDS)|Massachusetts General Hospital | Low Back Pain|Back Pain With Radiation|Back Pain Without Radiation|Back Pain Lower Back Chronic|Back Ache|Pain, Chronic | October 10, 2017 | Phase 2 |
NCT02140164 | National Eye Institute (NEI)|The Emmes Company, LLC|National Institutes of Health Clinical Center (CC) | Retinitis Pigmentosa | May 2014 | Phase 1|Phase 2 |
NCT02133885 | University of Florida|National Heart, Lung, and Blood Institute (NHLBI) | Hypertension | December 2023 | Phase 1|Phase 2 |
NCT02569307 | Pakistan Institute of Living and Learning | At Risk Mental State (ARMS)|Psychosis | October 2015 | Phase 2 |
NCT01493622 | Central South University | Schizophrenia | June 2010 | Phase 4 |
NCT02056665 | Puerta de Hierro University Hospital | Angelman Syndrome | January 2014 | Phase 2 |
NCT05586815 | Mahidol University | Acinetobacter Infections | January 10, 2023 | Phase 4 |
NCT00277355 | Merit Cudkowicz|FDA Office of Orphan Products Development|Huntington Study Group | Huntington Disease | April 2006 | Phase 2|Phase 3 |
NCT00063193 | University of Rochester|National Institute of Neurological Disorders and Stroke (NINDS) | Parkinson´s Disease | May 2003 | Phase 2 |
NCT01120899 | National Eye Institute (NEI)|The Emmes Company, LLC|National Institutes of Health Clinical Center (CC) | Diabetic Macular Edema | April 2010 | Phase 1|Phase 2 |
NCT05575427 | Mahidol University | Hospital Infections | November 24, 2022 | Phase 4 |
NCT00630942 | Mayo Clinic | Primary Sclerosing Cholangitis | February 2003 | Phase 1 |
NCT02297412 | Academic and Community Cancer Research United|National Cancer Institute (NCI) | Acute Pain|Breast Carcinoma|Peripheral Neuropathy | November 2014 | Phase 2 |
NCT03888378 | Hovione Scientia Limited | Meibomian Gland Dysfunction|MGD-Meibomian Gland Dysfunction | April 2, 2019 | Phase 2 |